Rezaltas:医薬品の世界市場規模、市販状況、特許、APIメーカー分析2015

調査会社DelveInsight社が発行したリサーチレポート(データ管理コード:DID2015API226)
◆英語タイトル:Rezaltas-API Insights, 2015
◆発行会社/調査会社:DelveInsight
◆商品コード:DID2015API226
◆発行日:2015年版(※最新版はお問い合わせください)
◆調査対象地域:グローバル
◆産業分野:製薬
◆ページ数:約20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール(納品まで約3営業日)
◆販売価格オプション(消費税別)
Single User(1名使用)USD500 ⇒換算¥56,500見積依頼/購入/質問フォーム
Site Price(同一国内共有可)USD1,000 ⇒換算¥113,000見積依頼/購入/質問フォーム
Enterprise Price(複数国内共有可)USD1,500 ⇒換算¥169,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
DelveInsight社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[Rezaltas:医薬品の世界市場規模、市販状況、特許、APIメーカー分析2015]についてメールでお問い合わせはこちら
当調査レポートでは、Rezaltas医薬品市場について調査・分析し、医薬品の概要、世界販売量予測、作用機序、薬力学的特性、薬物動態学的特性、アメリカ及びヨーロッパでの市販状況、特許情報、世界各地域別APIメーカー分析情報などを以下の構成でお届けいたします。※本レポートはご注文を頂いてから、最新データに更新して納品しているため、正確なページ数を明記しておりません。

・医薬品の概要
・世界販売量予測データ
・医薬品の説明
・作用機序(MOA)
・薬力学的特性
・薬物動態学的特性
・市販状況:アメリカ、ヨーロッパ
・特許情報
・特許権及び独占権(Exclusivity)存続期間
・グローバルAPIメーカー:地域別分析
・企業概要
*** レポート概要(サマリー)***

Summary
DelveInsight’s, Rezaltas-API Insights, 2015,report provides Rezaltas marketed details and API Manufacturers details across the globe along with the location. DelveInsight’s report gives the clear idea on the United States Drug Master File (USDMF) and Europe DMF filed by worldwide countries related to the Rezaltas. The Report provides the India and China API Manufactures who are driving the current API Market. DelveInsight’s report also highlights the patent, patent exclusivity information and competitive landscape. The research analysis also presents the Rezaltas Global sales forecasts data till 2016.
The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market.
India and China produce a large percentage of a majority of the APIs and intermediates produced in the world currently. The USFDA and EMA have strict guidelines for API manufacturing ‘Process Validation: General Principles and Practices’. While countries such as Japan and Singapore are signatories to the ICH Q7 regulation, India and China follow their national GMP guidelines. The efficiency and expertise of Asian contract manufacturers have positioned them in a very strategic space in the global pharmaceutical supply chain, with a vast majority of the APIs and intermediates being sourced from markets such as India and China.

[Data Sources]
The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts.
Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated drug.


Scope

• A review of the Rezaltas based on information derived from company and industry-specific sources
• Coverage of the Marketed data of the Rezaltas on the basis of MOA, target, dosage, route of administration, molecule type, strength, Chemical type and ATC Classification
• Coverage of the United States Drug Master File (US DMF), Active Substance Master File/EU DMF and API Manufactures in China & India for drug with location details.
• Patent Expiry Timeline and Exclusivity Details
• Global Forecasted Sales Figure from 2012-2016
• Qualitative and quantitative assessment of market space


*** レポート目次(コンテンツ)***

Table of Contents

• Drug Overview
• Global Sales Assessment
• Product Description
• Mechanism of Action
• Pharmacodynamic Properties
• Pharmacokinetic Properties
• Marketed Details for the United States
• Marketed Details for the Europe
• Patent Information
• Patent and Exclusivity Expiry Assessment United States (US)
• Patent Numbers and Expiry Details
• Patent Details
• Global API Manufacturers Assessment
• The United States Drug Master File (US DMF)
• The Europe Drug Master File (EUDMF)/Active Substance Master File (ASMF)
• The Active Pharmaceutical Ingredient (API) Manufacturers in the ASIA Region
• The Active Pharmaceutical Ingredient (API) Manufacturers by the United States Drug Master (DMF) File Status
• The Active Pharmaceutical Ingredient (API) Manufacturers by Region
• The Active Pharmaceutical Ingredient (API) Manufacturers by Location/Countries
• Generic Players
• Company Profile
• Summary
• Company Financials
• References
• Appendix
• Methodology
• About DelveInsight
• Contact Us
• Disclaimer

List of Tables
• Rezaltas, Market, Global Sales (in USD), 2015
• Rezaltas, Description
• Rezaltas, Marketed Details the United States (US)
• Rezaltas, Marketed Details the Europe (EU)
• Rezaltas, Patent/Exclusivity Expiry (Year), 2015
• Rezaltas, Patent Number Specific Patent Expiry (Year), 2015
• Rezaltas, Patent Details
• Rezaltas, the United States Drug Master File (US DMF), 2015
• Rezaltas, the Europe Drug Master File (EUDMF)/Active Substance Master File (ASMF), 2015
• Rezaltas, the API Manufacturers, China, 2015
• Rezaltas, the API Manufacturers, India, 2015
• Rezaltas, the API Manufacturers by the US DMF Status, 2015
• Rezaltas, the API Manufacturers by Region, 2015
• Rezaltas, the API Manufacturers by Location/Countries, 2015
• Rezaltas, Generic Players, 2015
• Company Overview, 2015

List of Figures
• Rezaltas, Market, Global Sales (in million USD), 2015
• Rezaltas, Global Sales % Change, 2015
• Rezaltas, Patent/Exclusivity Expiry (Year), 2015
• Rezaltas, Patent Number Specific Patent Expiry (Year), 2015
• Rezaltas, the API Manufacturers by the US DMF Status (%), 2015
• Rezaltas, the API Manufacturers by Region, 2015
• Rezaltas, the API Manufacturers by Location/Countries, 2015
• Rezaltas, Generic Players, 2015

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
  • インドの口腔衛生製品市場インサイト
    SummaryThe Oral Hygiene market in India is forecast to register moderate growth in value and volume terms during 2015-2020, due to rising consumer awareness of oral care practices and products. Toothpaste is the leading category by value, while the Mouthwash category is forecast to register fastest …
  • Focus Solutions Group plc:企業SWOT分析(IT・通信業界)
    Summary This comprehensive SWOT profile of Focus Solutions Group plc provides you with an in-depth strategic analysis of the company's businesses and operations. The profile will give you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and t …
  • オルソキシレンの世界市場動向・予測
    The present report is an essential resource for a one looking for detailed information on the world orthoxylene market. The report covers data on global, regional and national markets including present and future trends for supply and demand, prices, and downstream industries. In addition to the ana …
  • ICT支出予測(中規模企業):オランダ・ユーティリティー産業部門 – ICT予算内訳予測
    Why was the report written? This report presents the output from Kable’s ICT spend prediction statistical model, a log-linear regression model that provides ICT spending predictions based on a company’s demographic profile. The statistical model has been developed using an extensive collection of su …
  • Myer Holdings Limited:企業概要、財務・SWOT分析
    Myer Holdings Limited Fundamental Company Report provides a complete overview of the company’s affairs. The report includes financial and SWOT information, industry analysis, opinions, estimates, Myer Holdings Limited annual and quarterly forecasts made by stock market experts. The report also enabl …
  • KMW(KMW CO. LTD.)の企業概要及び財務データ:韓国企業調査レポート
    韓国企業の概要及び財務データをまとめたレポートです。該当企業の設立日、住所、社員数、資本金、事業分野、連絡先、企業格付などの概要と、最近3年間の会計年度別貸借対照表(B/S)、損益計算書(P/L)、キャッシュ・フロー計算書(C/F)など財務データを調査しました。 韓国企業と取引する時、韓国に進出を検討する時、或いは韓国の競合企業を調べる時に、本データをご活用ください。追加のデータや詳しい情報が必要な場合は別途カスタムリサーチ(委託調査)サービスで対応致します。
  • 高純度テレフタル酸(PTA)の世界市場予測(~2023年)
    “The Purified Terephthalic Acid (PTA) market is projected to grow at a CAGR of 5.1% from 2018 to 2023.” The purified terephthalic acid market is estimated to be USD 48.14 billion in 2018 and is projected to reach USD 61.78 billion by 2023, at a CAGR of 5.1% from 2018 to 2023. The expansion of the te …
  • エアロゲルの世界市場
    Invention of Aerogel is a result of combined research and development in material science and technology. Aerogel is derived by replacement of the liquid component of the gel with a gas. It is mesoporous solid foam; composed of an interconnected nanostructure network that exhibits minimum 50% porosi …
  • 電気圧縮コネクタの世界市場2016
    The Global Electrical Compression Connectors Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Electrical Compression Connectors industry. Firstly, the report provides a basic overview of the industry including definitions, classifications, applica …
  • 日本の癌診断(検査)市場
    Complete report $8,800.  DataPack (test volumes, sales forecasts, supplier shares) $5,700. “New Frontiers in the Japanese Cancer Diagnostics Market: Business Challenges, Emerging Technologies, Competitive Landscape” is Venture Planning Group’s new study of the major business o …
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(DID2015API226 )"Rezaltas:医薬品の世界市場規模、市販状況、特許、APIメーカー分析2015" (英文:Rezaltas-API Insights, 2015)はDelveInsight社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。